People and Business News — 6/21
The latest industry news of the past month, all in one place.
People News
Sharp has appointed Robert O’Beirn as Senior Vice President and Managing Director of its global Clinical Services business.
CROMSOURCE announced the appointment of Kris O’Brien as Global Head of TalentSource Life Sciences.
The IMA Group brought on Mike Minor as Executive Vice President of Clinical Research, and Debra Nichols as Senior Vice President of Commercial Affairs.
Clinical Ink announced the hiring of Janette Morgan as Executive Vice President, General Manager, EMEA.
Worldwide Clinical Trials, Inc. announced the promotion of Dave Bowser to Chief Operating Officer, and Sara Davis to Chief Commercial Officer.
Cytel Inc. has appointed Dr. Kyle Wathen as Vice President of Scientific Strategy and Innovation.
Signant Health announced the appointments of Jason Martin as Chief Operating Officer and Jean-Jacques Charhon as Chief Financial Officer.
Javara announced that it has appointed Brenda Reese as its first Chief Commercial Officer.
hyperCORE International chooses Seneca Harrison as their Internal Chief Diversity Officer.
Syneos Health announced the appointment of David S. Wilkes, MD, to the Company’s Board of Directors.
Business News
WCG IRB announced the launch of its 2021 International Fellows Program.
Yourway announced an expansion underway at its headquarters in Allentown, Pennsylvania, making the campus to over 300,000 square feet.
Recognition
Castor announced continued rapid adoption of its decentralized clinical trial platform to power COVID-19 studies globally.
OCT Clinical is among the top 3 CROs by the number of clinical trials launched in 2020, according to the Russian Registry of Clinical Trials.
Calyx announced that Calyx RIM has supported over 100 COVID-19 vaccine authorizations.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
